| 000 | 00510nam a2200193Ia 4500 | ||
|---|---|---|---|
| 008 | 220913s9999 xx 000 0 und d | ||
| 041 | _aeng | ||
| 082 | _a615.4 PAC | ||
| 100 | _aPachipulusu Rajesh | ||
| 245 | _aUS FDA regulatory requirements for ANDA submission and review phase assessment | ||
| 250 | _a1 | ||
| 260 | _c2019 | ||
| 300 | _a191p. | ||
| 502 | _aPramod Kumar T.M | ||
| 502 | _bJSS AHER | ||
| 502 | _cP.Regulatory Affairs | ||
| 650 | _aPharmaceutics - Regulations | ||
| 906 | _a2019-20 | ||
| 999 |
_c185848 _d185848 |
||